资讯

Zacks Investment Research on MSN3 小时

REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock?

Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has ...
Through this collaboration, Catalent supports Science 37’s Direct-to-Patient Clinical Trial Site model by providing reliable, efficient shipping and logistics services for study medications, ensuring ...
A midstage study of the psychedelic drug LSD showed positive results for easing symptoms in people with generalized anxiety ...
Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Precigen ( (PGEN)) has shared an update.
Discover why Novo Nordisk A/S’s 2025 restructuring and staff cuts shouldn't deter investors. Click to explore the long-term ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter.
Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to ...
Denis Johnson became CEO on Sept. 1 at the Grand Rapids-based contract manufacturer Grand River Aseptic Manufacturing.
FDA inspection revealed contamination and equipment issues at Novo Nordisk's Bloomington plant, acquired from Catalent in 2024. Inspectors found atypical particles, including hair, and pest ...
KeyBanc Capital Markets has initiated the coverage of Lifecore Biomedical (NASDAQ:LFCR) with a Sector Weight recommendation, noting a balanced outlook for the contract drug manufacturer’s growth ...